Dr. McGrath has over 22 years of clinical research and pharmaceutical business development experience. From 2013 to 2017, he was Vice President, Business Development, and Head of Search & Evaluation at Bristol-Myers Squibb (BMS), based in Princeton, NJ. During this period, the business development group executed over 50 major transactions in the therapeutic areas of oncology, neuroscience, cardiovascular, fibrosis, immuno-science, virology and genetically-defined diseases. In addition, Dr. McGrath was responsible for overseeing BMS’ venture capital investment portfolio ($350 million) and provided leadership for all global external partnering activities. From 2010 to 2013, he was Executive Director in Business Development responsible for neuroscience and virology business development. In 2005, Dr. McGrath joined the BMS virology clinical development group based in Wallingford, CT, as a director of clinical research, and became Group Director in 2007 and the REYATAZ® Development Lead. He oversaw multiple clinical virology programs resulting in seven major FDA filings for REYATAZ® and SUSTIVA®, and over 60 EMEA procedures submitted and fulfilled. From 1998 to 2005, Dr. McGrath was a physician-researcher in the Division of Geographic Medicine and Infectious Disease at Tufts-New England Medical Center, and an Assistant Professor of Medicine at Tufts Medical School in Boston. From 2002 to 2004, he was based at the Africa Center for Reproductive Health and Population Studies in KwaZulu Natal, South Africa, where he established an NIH-funded post-graduate training program in medical informatics with the University of KwaZulu Natal School of Medicine and worked on HIV clinical studies. Dr. McGrath earned his undergraduate degree at University College Dublin, his M.D. from the Royal College of Surgeons in Ireland, and his M.P.H. from the Harvard School of Public Health. He completed his residency in internal medicine at St. Elizabeth’s Medical Center, and fellowship in Infectious Disease at Tufts-New England Medical Center, both in Boston.